Literature DB >> 9479497

Multiple transcriptional variants and RNA editing in C18orf1, a novel gene with LDLRA and transmembrane domains on 18p11.2.

T Yoshikawa1, A R Sanders, L E Esterling, S D Detera-Wadleigh.   

Abstract

C18orf1 is a novel brain-expressed transcript, mapping to 18p11.2. Upon further characterization, we found multiple and differentially expressed transcriptional variants. C18orf1 alpha 1, an 8.5-kb transcript, was predicted to code for a 306-amino-acid protein and a 7.1-kb 3'-untranslated region (UTR). This variant was encoded by at least six exons. Alternative transcripts included alpha 2, identical to alpha 1 but missing 18 residues, and N-terminal-truncated variants termed beta 1 and beta 2. A motif search suggested the presence of a transmembrane domain in both alpha and beta and a low-density lipoprotein receptor class A (LDLRA) domain in the alpha-specific N-terminal. In LDLR, LDLRA has been shown to be involved in binding Ca2+ and LDL, raising the possibility that C18orf1 might bind Ca2+ and an unknown ligand. We also present evidence of RNA editing in the 5'-UTR of beta 2, the first demonstration of this phenomenon in 5'-UTR.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9479497     DOI: 10.1006/geno.1997.5118

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  2 in total

1.  Identification of multiple proteins expressed in murine embryos as binding partners for the WW domains of the ubiquitin-protein ligase Nedd4.

Authors:  C N Jolliffe; K F Harvey; B P Haines; G Parasivam; S Kumar
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

2.  Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling provides novel insights into prognostic evaluation of prostate cancer.

Authors:  Shashwat Sharad; Allissa Amanda Dillman; Zsófia M Sztupinszki; Zoltan Szallasi; Inger Rosner; Jennifer Cullen; Shiv Srivastava; Alagarsamy Srinivasan; Hua Li
Journal:  Oncotarget       Date:  2020-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.